Suzuki C K, Bonifacino J S, Lin A Y, Davis M M, Klausner R D
Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
J Cell Biol. 1991 Jul;114(2):189-205. doi: 10.1083/jcb.114.2.189.
Immunoglobulin heavy chain binding protein (BiP, GRP 78) coprecipitates with soluble and membrane-associated variants of the T-cell antigen receptor alpha chain (TCR-alpha) which are stably retained within the ER. Chelation of Ca2+ during solubilization of cells leads to the dissociation of BiP from the TCR-alpha variants, which is dependent upon the availability of Mg2+ and hydrolyzable ATP; this suggests that Ca2+ levels can serve to modulate the association/dissociation of these proteins with BiP. In vivo treatment of cells expressing either the soluble or membrane-anchored TCR-alpha variants with the Ca2+ ionophore, A23187, or an inhibitor of an ER Ca(2+)-ATPase, thapsigargin, or the membrane-permeant Ca2+ chelator BAPTA-AM, results in the redistribution of these proteins out of the ER and their subsequent secretion or cell surface expression. Under the same assay conditions, no movement of BiP out of the ER is observed. Taken together, these observations indicate that decreased Ca2+ levels result in the dissociation of a protein bound to BiP, leading to its release from ER retention. These data suggest that the intracellular fate of newly synthesized proteins stably associated with BiP can be regulated by Ca2+ levels in the ER.
免疫球蛋白重链结合蛋白(BiP,GRP 78)与稳定保留在内质网(ER)中的T细胞抗原受体α链(TCR-α)的可溶性和膜相关变体共沉淀。细胞溶解过程中Ca2+的螯合导致BiP与TCR-α变体解离,这取决于Mg2+和可水解ATP的可用性;这表明Ca2+水平可用于调节这些蛋白质与BiP的结合/解离。用Ca2+离子载体A23187、内质网Ca(2+)-ATP酶抑制剂毒胡萝卜素或膜渗透性Ca2+螯合剂BAPTA-AM对表达可溶性或膜锚定TCR-α变体的细胞进行体内处理,会导致这些蛋白质从内质网重新分布,并随后分泌或在细胞表面表达。在相同的检测条件下,未观察到BiP从内质网中移出。综上所述,这些观察结果表明Ca2+水平降低会导致与BiP结合的蛋白质解离,从而使其从内质网滞留中释放出来。这些数据表明,与BiP稳定结合的新合成蛋白质的细胞内命运可受内质网中Ca2+水平的调节。